CapsoVision, Inc. (NASDAQ:CV) Short Interest Up 171.0% in December

CapsoVision, Inc. (NASDAQ:CV) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 215,141 shares, a growth of 171.0% from the November 30th total of 79,381 shares. Based on an average daily trading volume, of 607,389 shares, the short-interest ratio is presently 0.4 days. Approximately 0.5% of the company’s shares are short sold. Approximately 0.5% of the company’s shares are short sold. Based on an average daily trading volume, of 607,389 shares, the short-interest ratio is presently 0.4 days.

Analyst Ratings Changes

A number of brokerages recently weighed in on CV. Weiss Ratings reiterated a “sell (e)” rating on shares of CapsoVision in a report on Monday. Zacks Research upgraded CapsoVision to a “hold” rating in a report on Wednesday, November 5th. Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a report on Friday, November 14th. Finally, Roth Capital set a $7.00 price target on shares of CapsoVision in a report on Tuesday, November 4th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $6.00.

Institutional Trading of CapsoVision

A hedge fund recently bought a new stake in CapsoVision stock. New York State Common Retirement Fund purchased a new position in shares of CapsoVision, Inc. (NASDAQ:CV) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,114 shares of the company’s stock, valued at approximately $34,000.

CapsoVision Trading Down 7.6%

Shares of NASDAQ CV traded down $1.05 during trading hours on Friday, hitting $12.83. 37,335 shares of the stock were exchanged, compared to its average volume of 163,420. CapsoVision has a one year low of $3.43 and a one year high of $15.37. The business’s 50 day moving average is $7.18.

CapsoVision (NASDAQ:CV) last released its earnings results on Thursday, November 13th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03). The business had revenue of $3.54 million for the quarter.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.